Brian Pomper
🏛️ Revolving DoorFormer Government Positions:
Ch Intl Trade Cnsl, Intl Trade Cnsl, Senate Fin
Ch. Intl Trade Counsel, Intl Trade Counsel, (D) Senate Fin.
🤖
AI Overview
Brian Pomper has appeared in 733 federal lobbying filings at Akin Gump Strauss Hauer & Feld, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 38 policy areas.
733
Total Filings
1
Firms
50
Clients
38
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 77 | 19 |
| 2019 | 131 | 30 |
| 2020 | 91 | 30 |
| 2021 | 107 | 31 |
| 2022 | 101 | 30 |
| 2023 | 98 | 29 |
| 2024 | 68 | 30 |
| 2025 | 60 | 29 |
Firms
Akin Gump Strauss Hauer & Feld733 filings
Top Clients
Innovation Alliance38 filings
Associations of Mexican Tomato Growers34 filings
Coupang, INC.32 filings
Anheuser-busch Companies, INC.27 filings
Polaris Industries27 filings
Biotechnology Innovation Organization25 filings
Pfizer INC24 filings
Gilead Sciences INC21 filings
Motion Picture Association of America20 filings
HP INC19 filings
Qualcomm Incorporated18 filings
Alliance for Trade Enforcement (Afte)17 filings
Genentech INC16 filings
National Fire Protection Association15 filings
Stanley Black & Decker, INC.15 filings
Trade Alliance for Health14 filings
Bayer Corporation (FKA Monsanto Company)12 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Follow the Money
Tracking lobbying dollars through the financial system.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.